BiomedicalPublications

MedComm

Wiley·China·ISSN 2688-2663

Open accessIn DOAJFee waivers availableBiochemistry, Genetics and Molecular Biology

Cost to publish

$3,500

Open-access article processing charge, list price.

Time to publication

10 wks

Broadly typical for the field.

h-index

78

OpenAlex citation statistic. Not a Journal Impact Factor.

2-year mean citedness

10.2

Average citations to articles from the previous two years.

What it costs to publish here

Publishing an open-access article in MedComm is listed at $3,500. The publisher also lists 3,050 EUR, 2,550 GBP. The journal reports that fee waivers are available — worth pursuing if you are funding this yourself or working from a lower-income country.

The journal's own fee page →

What this journal has charged over time

List price for an open-access article in MedComm, as recorded by OpenAlex for each year. The fee has risen 21% since 2021, from $2,900 to $3,500.

$0$1.8k$3.5k2021: $2,90020212022: $2,90020222023: $2,90020232024: $3,50020242025: $3,5002025

Publishers change list prices without notice and often apply discounts, institutional agreements or waivers. Treat this as the trend, and confirm the current figure with the journal.

Peer review and licensing

Review modelAnonymous peer review (policy)
LicenceCC BY
Author keeps copyrightYes
Plagiarism screeningYes
Editorial boardPublished →
LanguagesEN

Verification checks

8 of 8 confirmed

These are facts we could verify in public records, not a verdict. A journal missing a check is not necessarily disreputable — many long-established subscription journals sit outside the open-access registries entirely. Use them as questions to ask, and confirm anything that matters directly with the journal before you submit.

  • Listed in the Directory of Open Access JournalsDOAJ applies a documented set of inclusion criteria.
  • Included in OpenAlex's curated core setOpenAlex flags well-established venues that appear across major indexes.
  • Peer review model publicly declaredAnonymous peer review
  • Publication charges stated up frontA journal that will not tell you the fee before submission is worth a second look.
  • Screens submissions for plagiarismReported to DOAJ by the journal.
  • Participates in a digital preservation schemeArchiving means the record survives if the publisher does not.
  • Assigns persistent identifiers (DOIs)Standard practice; its absence is unusual.
  • Still actively publishingMost recent indexed article: 2026.

Scope

The subjects MedComm publishes most, derived from the topics assigned to its indexed articles.

Cancer Immunotherapy and BiomarkersImmune cells in cancerRNA modifications and cancerSARS-CoV-2 and COVID-19 ResearchEpigenetics and DNA MethylationImmune Cell Function and InteractionCancer-related molecular mechanisms researchFerroptosis and cancer prognosisAutophagy in Disease and TherapyMicroRNA in disease regulation

Publication record

Indexed articles1,735
Total citations31,503
i10-index602
Most recent indexed article2026
Open access since2020
All ISSNs2688-2663

Counts reflect what OpenAlex has indexed and will differ from the publisher's own figures. We do not show a founding year: OpenAlex's first-publication dates are distorted by mis-dated records — it puts PLoS ONE in 1806 — and we would rather omit a number than print one we cannot stand behind.